KMO and autoimmune disease: Stephens et al. (2013) found that inhibition of KMO activity or addition of exogenous kynurenine may be explained to a significant increase in Th17 lineage differentiation, and KMO may play the role of an endogenous AhR agonist in the background of ongoing autoimmune diseases.